Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease
- 1 September 1985
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 90 (3) , 399-403
- https://doi.org/10.1016/s0022-5223(19)38596-4
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Pulmonary artery growth during treatment with oral prostaglandin E2 in ductus dependent cyanotic congenital heart disease.Archives of Disease in Childhood, 1983
- Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.Circulation, 1981
- Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart diseaseThe Journal of Pediatrics, 1980
- The Blalock-Taussig anastomosis in infants younger than 1 week of age.Circulation, 1980
- Maintaining Patency of the Ductus Arteriosus for Palliation of Cyanotic Congenital Cardiac Malformations The Use of Prostaglandin E1 and Formaldehyde Infiltration of the Ductal WallAnnals of Surgery, 1980
- Effect of prostaglandin E1 on pulmonary circulation in pulmonary atresia. A quantitative morphometric study.Heart, 1980
- Long-term low-dose prostaglandin E1 administrationThe Journal of Pediatrics, 1980
- The Use of Prostaglandin E1 and Blalock-Taussig Shunts in Neonates with Cyanotic Congenital Heart DiseaseThe Annals of Thoracic Surgery, 1979
- Administration of prostaglandin E1 in neonates with critical congenital cardiac defectsThe Journal of Pediatrics, 1978
- E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.Circulation, 1976